- £34.41bn
- £37.84bn
- $7.52bn
Annual income statement for Experian, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 5,372 | 6,288 | 6,619 | 7,097 | 7,523 |
| Cost of Revenue | |||||
| Gross Profit | 4,511 | 5,288 | 5,549 | 5,908 | 6,179 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 4,200 | 4,871 | 5,355 | 5,403 | 5,730 |
| Operating Profit | 1,172 | 1,417 | 1,264 | 1,694 | 1,793 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 1,077 | 1,447 | 1,174 | 1,551 | 1,549 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 802 | 1,151 | 773 | 1,203 | 1,170 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 803 | 1,165 | 770 | 1,199 | 1,166 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | 803 | 1,165 | 770 | 1,199 | 1,166 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 1.01 | 1.38 | 1.17 | 1.46 | 1.46 |
| Dividends per Share |